Loading...
Incannex Healthcare Limited
IXHL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.63
$0.62(61.39%)
Incannex Healthcare Limited (IXHL) Financial Performance & Income Statement Overview
Review Incannex Healthcare Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
39.52%
↑ 39.52%
Net Income Growth
62.18%
↑ 62.18%
Operating Cash Flow Growth
-47.41%
↓ 47.41%
Operating Margin
-61450.00%
↓ 61450.00%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-51479.17%
↓ 51479.17%
ROE
-202.84%
↓ 202.84%
ROIC
-280.06%
↓ 280.06%
Incannex Healthcare Limited (IXHL) Income Statement & Financial Overview
Review Incannex Healthcare Limited's (IXHL) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $12000.00 | $12000.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $12000.00 | $12000.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $0.00 | $0.00 |
| R&D Expenses | $1.41M | $4.36M | $2.64M | $1.71M |
| SG&A Expenses | $3.60M | $5.40M | $5.34M | $2.48M |
| Operating Expenses | $5.02M | $9.76M | $7.98M | $4.19M |
| Total Costs & Expenses | $5.02M | $9.76M | $7.98M | $4.19M |
| Interest Income | $28000.00 | $40000.00 | $20000.00 | $0.00 |
| Interest Expense | $171000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $719000.00 | $62000.00 | $12000.00 | $1000.00 |
| EBITDA | -$5.004M | -$6.40M | -$5.24M | -$4.19M |
| EBITDA Ratio | -$417.00 | -$533.17 | $0.00 | |
| Operating Income | -$5.004M | -$9.74M | -$7.98M | -$4.19M |
| Operating Income Ratio | -$417.00 | -$812.00 | $0.00 | |
| Other Income/Expenses (Net) | -$890000.00 | $3.31M | $2.74M | $20000.00 |
| Income Before Tax | -$5.89M | -$6.43M | -$5.24M | -$4.17M |
| Income Before Tax Ratio | -$491.17 | -$535.92 | $0.00 | |
| Income Tax Expense | $0.00 | $30000.00 | $0.00 | $0.00 |
| Net Income | -$5.89M | -$6.46M | -$5.24M | -$4.17M |
| Net Income Ratio | -$491.17 | -$538.42 | $0.00 | |
| EPS | -$0.33 | -$0.38 | -$0.33 | -$0.26 |
| Diluted EPS | -$0.33 | -$0.38 | -$0.33 | -$0.26 |
| Weighted Avg Shares Outstanding | $17.62M | $17.04M | $15.87M | $15.87M |
| Weighted Avg Shares Outstanding (Diluted) | $17.62M | $17.04M | $15.87M | $15.87M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan